How to Get Prescribed Mounjaro for Weight Loss

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, originally developed as Mounjaro for type 2 diabetes, has emerged as a powerful weight loss medication in clinical practice. The medication works by activating two hormone receptors—GLP-1 and GIP—that regulate appetite and blood sugar, leading to an average weight loss of 20-22% in patients over 68 weeks according to the SURMOUNT-4 trial. PlexusDx provides access to compounded tirzepatide injections through licensed 503A pharmacies, making this therapy available nationwide without insurance requirements.

Understanding Tirzepatide and Its Weight Loss Mechanism

Tirzepatide belongs to a newer class of medications called dual GLP-1/GIP receptor agonists. Unlike earlier weight loss drugs that target only one pathway, tirzepatide activates both the glucagon-like peptide-1 receptor and the glucose-dependent insulinotropic polypeptide receptor simultaneously. This dual mechanism produces a stronger appetite-suppressing effect and improves metabolic regulation throughout the body.

Clinical research demonstrates that tirzepatide produces weight reductions greater than single-receptor GLP-1 agonists like semaglutide. Patients in the SURMOUNT trials experienced progressive weight loss over 68 weeks, with many achieving 25% or more total body weight reduction at the highest doses. The medication also improves cardiovascular risk markers, including blood pressure and cholesterol levels, in addition to weight loss outcomes.

PlexusDx Tirzepatide Prescription Process and Requirements

PlexusDx connects patients with licensed physicians who specialize in weight management and personalized GLP-1 therapy. The prescription process begins with an online consultation where your healthcare provider reviews your medical history, current medications, and weight loss goals. Once deemed appropriate, your provider issues a prescription that is filled by PlexusDx's network of licensed 503A compounding pharmacies within 5-7 business days.

To qualify for tirzepatide therapy through PlexusDx, patients must meet basic health screening criteria including stable vital signs and no active contraindications. Unlike brand-name Mounjaro which requires specific insurance coverage or out-of-pocket costs, PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan with no membership fees or insurance prerequisite. Your dose may need to go up as your body adjusts; your price won't.

Genetic Testing to Optimize Your Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The Precision Peptide Genetic Test is available as a $99 add-on after your first month of tirzepatide treatment. Results guide your PlexusDx provider in personalizing your dosing strategy, potentially accelerating your results and reducing side effects. Patients with favorable genetic profiles for GLP-1/GIP activation often experience faster weight loss trajectories and better appetite suppression at lower doses.

Cost, Accessibility, and Payment Options for Compounded Tirzepatide

PlexusDx compounded tirzepatide injections are priced at a flat rate of $289 per month, with no additional fees based on dose strength or frequency adjustments. This transparent pricing model eliminates the confusion of flat per-compound pricing found with many other weight loss providers. All medications are sourced from licensed 503A compounding pharmacies and shipped directly to your home in all 50 states.

PlexusDx tirzepatide is HSA and FSA eligible, allowing you to use pre-tax healthcare savings for treatment costs. The company requires no insurance, no membership fee, and no long-term contracts. Patients can start, pause, or adjust their treatment plan at any time based on their results and preferences. For those seeking an alternative to oral tirzepatide ($349/month) or exploring dual-compound options like GLP-Squared Injection ($289/month), injectable tirzepatide offers proven efficacy with straightforward monthly costs.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded tirzepatide the same as brand-name Mounjaro?

Compounded tirzepatide contains the identical active ingredient as Mounjaro but is manufactured by licensed 503A compounding pharmacies rather than the brand manufacturer. The chemical composition and clinical action are equivalent, though compounded versions typically cost significantly less and do not require insurance approval.

How much weight can I expect to lose with tirzepatide?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I get tirzepatide without insurance through PlexusDx?

Yes. PlexusDx tirzepatide injections require no insurance and are available to all 50 states for a flat price of $289 per month. Treatment is HSA/FSA eligible, and you can pay with standard payment methods without membership fees.

What are the common side effects of tirzepatide injections?

The most frequent side effects include mild nausea, vomiting, and gastrointestinal symptoms, particularly during dose escalation phases. Most side effects diminish within 1-2 weeks as the body adapts. Serious adverse events are rare when prescribed by qualified physicians who monitor patient tolerance and adjust dosing accordingly.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Mounjaro or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Mounjaro For Weight Loss 2
• Weight Loss Mounjaro
• Mounjaro Weight Loss By Week
• Weight Loss Injections Mounjaro

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.